These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
723 related articles for article (PubMed ID: 34297484)
1. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833 [TBL] [Abstract][Full Text] [Related]
4. The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration. Wu X; Wu Z; Xie Z; Huang H; Wang Y; Lv K; Yang H; Liu X Int Immunopharmacol; 2024 Sep; 138():112553. PubMed ID: 38943975 [TBL] [Abstract][Full Text] [Related]
5. DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma. Zuo X; Wang D; Tao C; Dou X; Zhao Z; Zhang J; Huang S; Li Y; Zhang X; Bu Y; Wang Y Front Biosci (Landmark Ed); 2024 May; 29(6):204. PubMed ID: 38940035 [TBL] [Abstract][Full Text] [Related]
6. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and Wu L; Jie B Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma. Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091 [TBL] [Abstract][Full Text] [Related]
9. SGO2 as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma. Chen Y; Xiang T Front Biosci (Landmark Ed); 2024 Aug; 29(9):314. PubMed ID: 39344317 [TBL] [Abstract][Full Text] [Related]
10. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma. Wang W; Li S Recent Pat Anticancer Drug Discov; 2024; 19(5):652-665. PubMed ID: 37877146 [TBL] [Abstract][Full Text] [Related]
13. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
14. Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells. Ma W; Hu J Genes Genomics; 2024 Jun; 46(6):713-731. PubMed ID: 38064156 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. Zhang L; Wang S; Wang L BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639 [TBL] [Abstract][Full Text] [Related]
16. CRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma. Tan L; Zhang H; Ding Y; Huang Y; Sun D Sci Rep; 2024 May; 14(1):11223. PubMed ID: 38755183 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
18. NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle Wu P; Zhao L; Zhang H; Lou Y; Chen D; Xue S; Liu X; Jiang H Oncol Res; 2024; 32(9):1439-1452. PubMed ID: 39220139 [TBL] [Abstract][Full Text] [Related]
19. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis. Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546 [TBL] [Abstract][Full Text] [Related]
20. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway. Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]